US 9737503
Short acting phenylalkylamine calcium channel blockers and uses thereof
granted A61KA61K31/216A61K31/26
Quick answer
US patent 9737503 (Short acting phenylalkylamine calcium channel blockers and uses thereof) held by Milestone Pharmaceuticals Inc. expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Milestone Pharmaceuticals Inc.
- Grant date
- Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/216, A61K31/26, A61K31/275, A61K31/277